Fonte: Il Messaggero
The approval of the coronavirus vaccine has been significantly accelerated. EMA’s human medicines committee has started the “rolling review” of the vaccine that has been developed by the University of Oxford in collaboration with the scientists at IRBM in Pomezia (Rome) and will be distributed worldwide by the multinational AstraZeneca. A “rolling review” is a regulatory tool that the Agency can use to speed up the assessment of a promising medicine or vaccine during a public health emergency.
Article by Francesco Marzoli published on Latina Oggi – 02/10/2020